Related Experiment Video
Updated: Jun 2, 2026

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Frontotemporal brain sagging syndrome: an SIH-like presentation mimicking FTD
M R Wicklund1, B Mokri, D A Drubach
1Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Neurology
|April 20, 2011
Summary
Frontotemporal brain sagging syndrome (FBSS) can mimic behavioral variant frontotemporal dementia (bvFTD). This condition, characterized by brain sagging, may be treatable and warrants recognition.
Area of Science:
- Neurology
- Neuroimaging
- Neurodegenerative Diseases
Background:
- Behavioral variant frontotemporal dementia (bvFTD) is a recognized syndrome linked to structural and metabolic changes in the frontal and temporal lobes.
- Frontotemporal brain sagging syndrome (FBSS) presents with features overlapping bvFTD, alongside evidence of brain sagging.
Purpose of the Study:
- To describe the clinical and imaging characteristics of patients with frontotemporal brain sagging syndrome (FBSS).
- To differentiate FBSS from typical bvFTD and highlight its potential treatability.
Main Methods:
- Retrospective chart review of patients diagnosed with FTD and imaging evidence of brain sag between 1996 and 2010.
- Analysis of clinical symptoms, functional imaging (hypometabolism), brain MRI findings (brain sagging, brainstem distortion), CSF analysis, and neuropathology.
Main Results:
- Eight patients (7 male, 1 female) diagnosed with FBSS, with median onset at 53 years.
- Common symptoms included behavioral/cognitive dysfunction, somnolence, and headache. Imaging showed frontotemporal hypometabolism and brain sagging.
- Neuropathology in two cases excluded neurodegenerative disease, suggesting FBSS is distinct from typical FTD.
Conclusions:
- Frontotemporal brain sagging syndrome (FBSS) can clinically and radiographically mimic bvFTD.
- Recognition of FBSS is crucial as it represents an unusual presentation that is potentially treatable.
Related Concept Videos
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Prosopagnosia
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...

